investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Alex Kentsis

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

James Y. Chen

Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating

Leukaemia

Kapil Bhalla

Novel Targeted Therapy for AML

Leukaemia

Marina Y Konopleva

Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia

Leukaemia

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Pathology Hematology and hematologic malignancies

Julia Kubanek

Ecological Leads for Drug Discovery from Marine Organisms

Leukaemia

Paul M Thompson

ENIGMA Center for Worldwide Medicine, Imaging & Genomics

Leukaemia

Nora C Heisterkamp

Role of Sialic Acid Modification in ALL Survival and Drug Resistance

Leukaemia

Pathology Hematology and hematologic malignancies

Tracy G Anthony

Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.

Leukaemia

Pediatric oncology or childhood cancer

Bruno Calabretta

Targeting the C/EBPalpha-Gfi-pathway in CML stem cells

Leukaemia

Pathology Hematology and hematologic malignancies